Henry ScheinHSIC
HSIC
About: Henry Schein Inc is a solutions company for healthcare professionals powered by a network of people and technology. The company is a provider of healthcare products and services to office-based dental and medical practitioners, as well as alternate sites of care. The company's reportable segments are global Distribution and Value-Added Services; global Specialty Products; and global Technology. It generates the majority of its revenue from the global Distribution and Value-Added Services segment which includes distribution to the global dental and medical markets of national brand and corporate brand merchandise, as well as equipment and related technical services.
Employees: 25,000
0
Funds holding %
of 7,245 funds
0
Analysts bullish %
of 4 analysts
Fund manager confidence
Based on 2025 Q1 regulatory disclosures by fund managers ($100M+ AUM)
652% more call options, than puts
Call options by funds: $117M | Put options by funds: $15.6M
30% more first-time investments, than exits
New positions opened: 92 | Existing positions closed: 71
10% more funds holding in top 10
Funds holding in top 10: 10 [Q4 2024] → 11 (+1) [Q1 2025]
2% more funds holding
Funds holding: 536 [Q4 2024] → 548 (+12) [Q1 2025]
0.8% less ownership
Funds ownership: 102.63% [Q4 2024] → 101.83% (-0.8%) [Q1 2025]
3% less capital invested
Capital invested by funds: $8.86B [Q4 2024] → $8.63B (-$224M) [Q1 2025]
23% less repeat investments, than reductions
Existing positions increased: 160 | Existing positions reduced: 208
Research analyst outlook
4 Wall Street Analysts provided 1 year price targets over the past 3 months
Low target
$75
4%
upside
Avg. target
$80
11%
upside
High target
$86
20%
upside
4 analyst ratings
2 positive
50%
2 neutral
50%
0 negative
0%
Wells Fargo Vik Chopra | 4%upside $75 | Equal-Weight Maintained | 6 May 2025 |
Barrington Research Michael Petusky | 20%upside $86 | Outperform Maintained | 6 May 2025 |
Piper Sandler Jason Bednar | 7%upside $77 | Overweight Maintained | 30 Apr 2025 |
UBS Kevin Caliendo | 11%upside $80 | Neutral Maintained | 26 Feb 2025 |
Financial journalist opinion
Based on 15 articles about HSIC published over the past 30 days
Neutral
Business Wire
2 days ago
Henry Schein One Unveils The Catalyst Index, a Look into Dentistry's Top 10%
AMERICAN FORK, Utah--(BUSINESS WIRE)--Henry Schein One today announced the launch of The 2025 Catalyst Index, its exclusive report offering dental practices an unparalleled view into the strategies transforming performance across the industry. Built on years of trusted benchmarking and informed by Henry Schein One's most connected platform, the fourth annual report, The Catalyst Index, raises the bar by revealing the specific actions that distinguish the top 10% of DSOs and private practices. “.
Positive
Seeking Alpha
5 days ago
Henry Schein Post Earnings Review
HSIC's Q1 earnings were solid, with full-year EPS guidance of $4.80-$4.94 and analysts expecting $5.27 in 2026. New business units and revamped sales incentives aim to reignite revenue growth after stagnation since 2022; management is optimistic about their impact. Ongoing share buybacks (32% reduction in shares since 2011) continue to support EPS and provide downside support for the stock.
Neutral
Business Wire
5 days ago
Henry Schein Announces Completion of Strategic Investment by KKR and Appointment of Dan Daniel to Board of Directors
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc. (Nasdaq: HSIC), the world's largest provider of health care solutions to office-based dental and medical practitioners, today announced the successful completion of a $250 million strategic investment by funds affiliated with KKR, a leading global investment firm. Upon the closing of this transaction, KKR has become the holder of approximately 12% of the common shares of Henry Schein. In connection with the investment, William K. “Dan” Daniel,.
Neutral
Business Wire
1 week ago
Henry Schein to Participate in Upcoming Investor Conference in June
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conference in June: Jefferies Global Healthcare Conference at the Marriott Marquis hotel, New York City, on June 4, 2025, at 1:20 p.m. Eastern time. Henry Schein's presentations can be heard via live webcast by visiting https://investor.henryschein.com/webcasts. Replays.
Negative
Benzinga
2 weeks ago
These Analysts Lower Their Forecasts On Henry Schein Following Q1 Results
Henry Schein Inc. HSIC reported mixed results for its first-quarter on Monday.
Neutral
Business Wire
2 weeks ago
Henry Schein to Participate in Upcoming Investor Conferences in May
MELVILLE, N.Y.--(BUSINESS WIRE)--Henry Schein, Inc., the world's largest provider of health care solutions to office-based dental and medical practitioners, announced today that the Company will present at the following investor conferences in May: Bank of America Healthcare Conference at the Encore Hotel in Las Vegas on May 14, 2025, at 10:00 a.m. Pacific time (1:00 p.m. Eastern time). Stifel Jaws & Paws Conference at Lotte Hotel, New York City, on May 29, 2025, at 12:40 p.m. Eastern time.
Neutral
Seeking Alpha
2 weeks ago
Henry Schein, Inc. (HSIC) Q1 2025 Earnings Call Transcript
Henry Schein, Inc. (NASDAQ:HSIC ) Q1 2025 Earnings Conference Call May 5, 2025 8:00 AM ET Company Participants Graham Stanley - VP of IR and Strategic Financial Project Officer Stanley Bergman - Chairman and CEO Ron South - SVP and CFO Conference Call Participants Jon Block - Stifel Jason Bednar - Piper Sandler Jeff Johnson - Baird Mike Petusky - Barrington Research Allen Lutz - Bank of America John Stansel - JPMorgan Vik Chopra - Wells Fargo Brandon Vazquez - William Blair Elizabeth Anderson - Evercore ISI Operator Good morning, ladies and gentlemen. Welcome to Henry Schein's First Quarter 2025 Earnings Conference Call.
Positive
Zacks Investment Research
2 weeks ago
Compared to Estimates, Henry Schein (HSIC) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for Henry Schein (HSIC) give a sense of how its business performed in the quarter ended March 2025, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Negative
Zacks Investment Research
2 weeks ago
Henry Schein Q1 Earnings Top Estimates, Revenues Miss, Stock Falls
HSIC ends the first quarter of 2025 on a mixed note.
Negative
Reuters
2 weeks ago
Henry Schein misses quarterly revenue estimates on weak demand for dental products
Medical supplies distributor Henry Schein Inc on Monday missed first-quarter revenue estimates, hurt by muted demand for its dental products amid rising inflation.
Charts implemented using Lightweight Charts™